Clofarabine Combinations in Adults with Refractory/Relapsed Acute Lymphoblastic Leukemia (ALL): A GRAALL Report

被引：0
|
作者：
Pigneux, Arnaud [1 ]
Sauvezie, Mathieu [2 ]
Vey, Norbert [3 ]
Raffoux, Emmanuel
Marcais, Ambroise
Huguet, Francoise [5 ]
Rousselot, Philippe [6 ]
Marolleau, Jean Pierre [7 ]
Lepretre, Stephane [8 ]
Turlure, Pascal [9 ]
Chevallier, Patrice [10 ]
Hunault, Mathilde [11 ]
Bonmati, Caroline [12 ]
Cluzeau, Thomas [13 ]
Leguay, Thibaut [14 ]
Ifrah, Norbert [11 ]
Dombret, Herve [4 ]
机构：
[1] CHU Bordeaux, Pessac, France
[2] Hop Haut Leveque, Serv Hematol Clin & Therapie Cellulaire, Pessac, France
[3] Univ Marseille, Inst J Paoli I Calmettes, Marseille, France
[4] Univ Paris 07, Hop St Louis, AP HP, EA 3518, Paris, France
[5] Univ Toulouse, Hop Purpan, Toulouse, France
[6] Univ Versailles St Quentin Yvelines, Hop Versailles, Le Chesnay, France
[7] Hop SUD, Hematol Unit, Amiens 1, France
[8] Ctr Henri Becquerel, F-76038 Rouen, France
[9] Univ Limoges, CHU Dupuytren, Limoges, France
[10] CHU Nantes, Dept Hematol, F-44035 Nantes 01, France
[11] CHU Angers, Serv Hematol, Angers, France
[12] Hop Brabois, Vandoeuvre Les Nancy, France
[13] CHU Archet, Serv Hematol, Nice, France
[14] Univ Bordeaux, Hop Haut Leveque, Pessac, France
来源：
BLOOD | 2011年 / 118卷 / 21期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：1110 / 1110
页数：1
相关论文
共 50 条
  • [21] IMPACT OF REINDUCTION REGIMENS FOR RELAPSED AND REFRACTORY ACUTE LYMPHOBLASTIC-LEUKEMIA IN ADULTS
    WELBORN, JL
    AMERICAN JOURNAL OF HEMATOLOGY, 1994, 45 (04) : 341 - 344
  • [22] Outcome of adults with relapsed/refractory T-cell acute lymphoblastic leukemia or lymphoblastic lymphoma
    Samra, Bachar
    Alotaibi, Ahmad S.
    Short, Nicholas J.
    Khoury, Joseph D.
    Ravandi, Farhad
    Garris, Rebecca
    Jain, Nitin
    Konopleva, Marina
    Kantarjian, Hagop
    Jabbour, Elias
    AMERICAN JOURNAL OF HEMATOLOGY, 2020, 95 (09) : E245 - E247
  • [23] Outcome of Adults with Relapsed/Refractory T-Cell Acute Lymphoblastic Leukemia or Lymphoblastic Lymphoma
    Samra, Bachar
    Alotaibi, Ahmad S.
    Short, Nicholas
    Khoury, Joseph
    Ravandi, Farhad
    Garris, Rebecca
    Jain, Nitin
    Konopleva, Marina
    Kantarjian, Hagop
    Jabbour, Elie
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2020, 20 : S170 - S170
  • [24] Cytarabine with a single high dose of idarubicin as induction therapy for adults with relapsed or refractory acute lymphoblastic leukemia (ALL).
    Weiss, MA
    Aliff, TB
    Tallman, MS
    Frankel, SR
    Kalaycio, ME
    Maslak, PG
    Scheinberg, DA
    Roma, TE
    BLOOD, 2000, 96 (11) : 719A - 719A
  • [25] Phase 2 Study of Blinatumomab in Japanese Adults with Relapsed/Refractory Acute Lymphoblastic Leukemia (R/R ALL)
    Kobayashi, Yukio
    Zimmerman, Zachary F.
    Oh, Iekuni
    Maeda, Yoshinobu
    Minami, Hironobu
    Miyamoto, Toshihiro
    Sakura, Toru
    Iida, Hiroatsu
    Chen, Yuqi
    Kiyoi, Hitoshi
    BLOOD, 2018, 132
  • [26] Clofarabine Based Chemotherapy in Adult Relapsed/Refractory Acute Lymphoblastic Leukemia/Lymphoma-a Single Institution Experience
    Alkhateeb, Hassan B.
    Damlaj, Moussab
    Lin, Tasha
    Al-Kali, Aref
    Sproat, Lisa
    Betcher, Jeffrey Alan
    Barreto, Jason N.
    Hashmi, Shahrukh K.
    Patnaik, Mrinal M.
    Gangat, Naseema
    Elliott, Michelle
    Litzow, Mark R.
    Hogan, William J.
    BLOOD, 2015, 126 (23)
  • [27] Phase 2 Results of Clofarabine In Combination with Etoposide and Cyclophosphamide In Pediatric Patients with Refractory or Relapsed Acute Lymphoblastic Leukemia
    Huiya, Nobuko
    Paul, Jo-Anne
    Borowitz, Michael J.
    Thomson, Blythe
    Isakoff, Michael
    Silverman, Lewis B.
    Steinherz, Peter G.
    Kadota, Richard
    Pressey, Joseph G.
    Shen, Violet
    Chu, Roland
    Cooper, Todd
    Jeha, Sima
    Razzouk, Bassem I.
    Rytting, Michael E.
    Barry, Elly
    Carroll, William L.
    Gaynon, Paul
    BLOOD, 2010, 116 (21) : 378 - 379
  • [28] Results of a phase I study of clofarabine (CLO) plus cyclophosphamide (CY) in adult patients (pts) with relapsed and/or refractory acute lymphoblastic leukemia (ALL)
    Faderl, S.
    Thomas, D. A.
    Gandhi, V.
    Huang, X.
    Borthakur, G.
    O'Brien, S.
    Ravandi, F.
    Plunkett, W.
    Bretz, J. L.
    Kantarjian, H. M.
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
  • [29] Phase 2 trial of clofarabine in combination with etoposide and cyclophosphamide in pediatric patients with refractory or relapsed acute lymphoblastic leukemia
    Hijiya, Nobuko
    Thomson, Blythe
    Isakoff, Michael S.
    Silverman, Lewis B.
    Steinherz, Peter G.
    Borowitz, Michael J.
    Kadota, Richard
    Cooper, Todd
    Shen, Violet
    Dahl, Gary
    Thottassery, Jaideep V.
    Jeha, Sima
    Maloney, Kelly
    Paul, Jo-Anne
    Barry, Elly
    Carroll, William L.
    Gaynon, Paul S.
    BLOOD, 2011, 118 (23) : 6043 - 6049
  • [30] COMBINATION OF CLOFARABINE AND CYTARABINE IN THE TREATMENT OF REFRACTORY OR RELAPSED ACUTE MYELOID LEUKEMIA
    Spassov, B.
    Balatzenko, G.
    Angelova, S.
    Toshkov, S.
    Guenova, M.
    Arnaudov, G.
    Mihaylov, G.
    HAEMATOLOGICA, 2015, 100 : 377 - 377
12345